Alemtuzumab, Fludarabine and Melphalan as a Conditioning Therapy in Severe Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome—Single Center Experience
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.